Navigation Links
The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Date:2/8/2013

Boca Raton, FL (PRWEB) February 08, 2013

The producers of the In View TV series, an educational TV series hosted by Larry King, have announced plans to focus on autoimmune diseases and the push to cure them in an upcoming series. These diseases, which have no cure and often have nebulous causes, afflict tens of millions of Americans, affecting their health and quality of life. Diseases that come under this classification include type-I diabetes, multiple sclerosis and rheumatoid arthritis. The In View Larry King show, which runs on cable outlets across the country, will inform TV audiences about some of the many autoimmune diseases, in which the body’s immune system attacks and destroys healthy tissues and cells, as well as efforts to cure these diseases and develop better treatments for them. The Larry King TV show will spotlight researchers as well as companies across the country working to develop cures and treatments.

In November, researchers at the National Institute of Biomedical Imaging and Bioengineering announced a possible breakthrough in the treatment of autoimmune diseases. The institute’s approach involved re-educating the body’s T-cells to not attack healthy tissue. This series of the In View with Larry King show (http://www.inviewseries.com) will look at advances such as this and more, giving rare attention to diseases and patients that often get overlooked. The In View TV series (855-446-8439) will showcase organizations and companies that have made progress in the fight against various autoimmune disorders and diseases.

The Larry King In View show (561-544-7965) offers enlightening episodes and series on many important and timely subjects throughout American culture. It features veteran television personality Larry King, the long-time host of “Larry King Live” on CNN.

Read the full story at http://www.prweb.com/releases/in-view-with-larry-king/autoimmune-diseases/prweb10413646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. Management Matters Series Starts with “Lab Budgeting 101”
4. QSI Announces RS Series of Deep Cooled CCD Cameras
5. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
6. Rudy Mazzocchi Prepares to Release the Second Thriller in The EQUITY Series Trilogy, entitled EQUITY of FEAR
7. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
8. BioTechniques Announces the Publication of 'Transfection' – The First Issue of a New, Digital-Only Spotlight Series
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. Advanced Cell Diagnostics Completes $12 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... ... FireflySci Inc. is a go-getter type of company that continues to grow ... main factors. The first is the amazing customer service that the FireflySci staff ... around the world. , 2016 was a tremendous sales year for FFS and much ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):